METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for METASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost immune system against advanced kidney cancer before surgery
Disease control TerminatedThis study tested whether giving a drug called pembrolizumab, with or without another drug called axitinib, before and after surgery could help people with advanced kidney cancer. The goal was to see if this approach could better control the cancer and reduce the chance of it com…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Early trial tests new combo to fight advanced kidney cancer
Disease control TerminatedThis early-stage study tested the safety and best dose of a two-drug immunotherapy combination for people with advanced kidney cancer that has spread. The trial combined pembrolizumab, a drug that helps the immune system attack cancer, with aldesleukin, which stimulates immune ce…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug combo tested for Tough-to-Treat kidney cancer
Disease control TerminatedThis study tested a two-drug combination for people with advanced kidney cancer (clear cell RCC) that had spread and worsened after they received standard treatments, including immunotherapy. The goal was to see if adding a pill called sitravatinib to an immunotherapy drug (nivol…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC